Programming the Next Generation of Living Medicine
Q-Immune designs and develops predictable, safe, and accessible cell therapies to address the world’s most complex diseases. By decoding the language of cells , we program artificial protein interaction networks to function as the drug itself.
Complex Diseases Require Dynamic Insights
Cell therapies like CAR-T have the potential to cure, but their unpredictable and life-threatening toxicities currently prevent them from being used as first-line treatments. Today, these therapies are developed using tools that only capture static snapshots of cellular function.
However, there are downsides to this approach. By only looking at the surface, standard 'omics' approaches miss the dynamic, real-time protein networks that dictate how a cell actually behaves—and ultimately determine whether a therapy will succeed or fail.
At Q-Immune, we are mapping dynamic protein interaction networks to find a new way to treat complex diseases.
Decoding the language of cells
To program cells, you have to speak their language. We decode their language. Our Quantitative Multiplex co-Immunoprecipitation (QMI) technology captures the real-time conversations happening between proteins inside living cells.
Unlike traditional technologies, our platform decodes how these protein networks dynamically assemble and change. This allows us to identify biosignatures that predict clinical toxicities and performance. By understanding the language of our cells, we can engineer safety directly into the therapies, transforming CAR-T into a predictable bioengineered product.
The QMI Platform
Powered by patented signalosome profiling and advanced A.I., our platform is a new engine for living medicine. We use these unprecedented insights to drive a continuous cycle of discovery, optimization, and clinical translation.
How it works
Map the Native Network
Decode the Biosignatures
Program the cells
Test in vitro and in vivo
Get in touch if you are interested in partnering with us.
